medical cannabis
-
On the road to positive cash flow, biopharmaceutical company Avicanna launches its proprietary Pura H&W™
The cannabis sector has had a bit of a rough go over the last year or so, to…
-
Biden’s win brings a “green” market wave and cannabis extraction team attracts the Sixth Wave
“Waves are inspiring not because they rise and fail, but because each time they fall. They never fail…
-
FinCanna Capital’s CEO on being the only pure royalty company in the cannabis industry
InvestorIntel’s Tracy Weslosky spoke with Andriyko Herchak, CEO of FinCanna Capital Corp. (CSE: CALI | OTCQB: FNNZF), about…
-
Herchak on how FinCanna offers investors a way to invest in top quality private cannabis companies
“FinCanna is diversified by investing in four companies to date. We have enough money for a fifth investment.…
-
David Sutton on innovation in the cannabis market and what’s next for NanoSphere Health Sciences
“Listing in Canada gave us enormous exposure as well as helped us identify a partner, a licensed producer,…
-
Global Cannabis Applications’ Brad Moore on the impact of artificial intelligence in the medicinal marijuana market
April 29, 2018 – “We use different forms of artificial intelligence to actually come up with a product…
